These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 21814754)

  • 21. Anti-citrullinated protein antibodies and high levels of rheumatoid factor are associated with systemic bone loss in patients with early untreated rheumatoid arthritis.
    Bugatti S; Bogliolo L; Vitolo B; Manzo A; Montecucco C; Caporali R
    Arthritis Res Ther; 2016 Oct; 18(1):226. PubMed ID: 27716332
    [TBL] [Abstract][Full Text] [Related]  

  • 22.
    Guzmán-Guzmán IP; Ramírez-Vélez CI; Falfán-Valencia R; Navarro-Zarza JE; Gutiérrez-Pérez IA; Zaragoza-García O; Ramírez M; Castro-Alarcón N; Parra-Rojas I
    Front Immunol; 2021; 12():718246. PubMed ID: 34421923
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Outcome of patients with early arthritis without rheumatoid factor and ACPA and predictors of rheumatoid arthritis in the ESPOIR cohort.
    Mouterde G; Rincheval N; Lukas C; Daien C; Saraux A; Dieudé P; Morel J; Combe B
    Arthritis Res Ther; 2019 Jun; 21(1):140. PubMed ID: 31171038
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Missing Anticitrullinated Protein Antibody Does Not Affect Short-term Outcomes in Early Inflammatory Arthritis: From the Canadian Early Arthritis Cohort.
    Shu J; Bykerk VP; Boire G; Haraoui B; Hitchon C; Thorne JC; Tin D; Keystone EC; Pope JE;
    J Rheumatol; 2015 Nov; 42(11):2023-8. PubMed ID: 26329342
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Anti-CCP2 is an adjunct to, not a surrogate for, rheumatoid factor in the diagnosis of rheumatoid arthritis: diagnostic utility of anti-CCP2 antibodies in Egyptian patients with rheumatoid arthritis.
    Abdel-Nasser AM; Mahmoud MH; El Mansoury TM; Osman AM
    Scand J Rheumatol; 2008; 37(5):329-36. PubMed ID: 18666028
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Value of anti-modified citrullinated vimentin and third-generation anti-cyclic citrullinated peptide compared with second-generation anti-cyclic citrullinated peptide and rheumatoid factor in predicting disease outcome in undifferentiated arthritis and rheumatoid arthritis.
    van der Linden MP; van der Woude D; Ioan-Facsinay A; Levarht EW; Stoeken-Rijsbergen G; Huizinga TW; Toes RE; van der Helm-van Mil AH
    Arthritis Rheum; 2009 Aug; 60(8):2232-41. PubMed ID: 19644872
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Autoantibodies are major predictors of arthritis development in patients with anti-citrullinated protein antibodies and musculoskeletal pain.
    Eloff E; Martinsson K; Ziegelasch M; Cedergren J; Reckner Å; Skogh T; Karlsson L; Ärlemalm A; Borggreven NV; Trouw LA; Kastbom A
    Scand J Rheumatol; 2021 May; 50(3):189-197. PubMed ID: 33243072
    [No Abstract]   [Full Text] [Related]  

  • 28. Association between number and type of different ACPA fine specificities with lung abnormalities in early, untreated rheumatoid arthritis.
    Joshua V; Hensvold AH; Reynisdottir G; Hansson M; Cornillet M; Nogueira L; Serre G; Nyren S; Karimi R; Eklund A; Sköld M; Grunewald J; Chatzidionysiou K; Catrina A
    RMD Open; 2020 Sep; 6(2):. PubMed ID: 32917833
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Treatment outcomes in patients with seropositive versus seronegative rheumatoid arthritis in Phase III randomised clinical trials of tofacitinib.
    Bird P; Hall S; Nash P; Connell CA; Kwok K; Witcombe D; Thirunavukkarasu K
    RMD Open; 2019; 5(1):e000742. PubMed ID: 30886732
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Combination of anti-citrullinated protein antibodies and rheumatoid factor is associated with increased systemic inflammatory mediators and more rapid progression from preclinical to clinical rheumatoid arthritis.
    Lingampalli N; Sokolove J; Lahey LJ; Edison JD; Gilliland WR; Holers VM; Deane KD; Robinson WH
    Clin Immunol; 2018 Oct; 195():119-126. PubMed ID: 29842946
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Alveolar bone loss is associated with circulating anti-citrullinated protein antibody (ACPA) in patients with rheumatoid arthritis.
    Gonzalez SM; Payne JB; Yu F; Thiele GM; Erickson AR; Johnson PG; Schmid MJ; Cannon GW; Kerr GS; Reimold AM; Sokolove J; Robinson WH; Mikuls TR
    J Periodontol; 2015 Feb; 86(2):222-31. PubMed ID: 25299390
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Rheumatoid factor isotypes in relation to antibodies against citrullinated peptides and carbamylated proteins before the onset of rheumatoid arthritis.
    Brink M; Hansson M; Mathsson-Alm L; Wijayatunga P; Verheul MK; Trouw LA; Holmdahl R; Rönnelid J; Klareskog L; Rantapää-Dahlqvist S
    Arthritis Res Ther; 2016 Feb; 18():43. PubMed ID: 26860413
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Autoantibodies in rheumatoid arthritis: rheumatoid factors and anticitrullinated protein antibodies.
    Song YW; Kang EH
    QJM; 2010 Mar; 103(3):139-46. PubMed ID: 19926660
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The association between anti-carbamylated protein (anti-CarP) antibodies and radiographic progression in early rheumatoid arthritis: a study exploring replication and the added value to ACPA and rheumatoid factor.
    Ajeganova S; van Steenbergen HW; Verheul MK; Forslind K; Hafström I; Toes RE; Huizinga TW; Svensson B; Trouw LA; van der Helm-van Mil AH
    Ann Rheum Dis; 2017 Jan; 76(1):112-118. PubMed ID: 27117699
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Different properties of ACPA and IgM-RF derived from a large dataset: further evidence of two distinct autoantibody systems.
    Ursum J; Bos WH; van de Stadt RJ; Dijkmans BA; van Schaardenburg D
    Arthritis Res Ther; 2009; 11(3):R75. PubMed ID: 19460147
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Smoking in combination with antibodies to cyclic citrullinated peptides is associated with persistently high levels of survivin in early rheumatoid arthritis: a prospective cohort study.
    Svensson B; Hafström I; Erlandsson MC; Forslind K; Bokarewa MI
    Arthritis Res Ther; 2014 Jan; 16(1):R12. PubMed ID: 24428870
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Anti-cyclic citrullinated peptide but not rheumatoid factor is associated with ultrasound-detected bone erosion among rheumatoid arthritis patients with at least moderate disease activity.
    Tan YK; Li H; Allen JC; Thumboo J
    Int J Rheum Dis; 2020 Oct; 23(10):1337-1343. PubMed ID: 33460311
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Triple Positivity for Anti-Citrullinated Protein Autoantibodies, Rheumatoid Factor, and Anti-Carbamylated Protein Antibodies Conferring High Specificity for Rheumatoid Arthritis: Implications for Very Early Identification of At-Risk Individuals.
    Verheul MK; Böhringer S; van Delft MAM; Jones JD; Rigby WFC; Gan RW; Holers VM; Edison JD; Deane KD; Janssen KMJ; Westra J; Brink M; Rantapää-Dahlqvist S; Huizinga TWJ; van der Helm-van Mil AHM; van der Woude D; Toes REM; Trouw LA
    Arthritis Rheumatol; 2018 Nov; 70(11):1721-1731. PubMed ID: 29781231
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Anti-Citrullinated Protein Antibody Specificities, Rheumatoid Factor Isotypes, and Incident Cardiovascular Events in Patients With Rheumatoid Arthritis.
    Westerlind H; Rönnelid J; Hansson M; Alfredsson L; Mathsson-Alm L; Serre G; Cornillet M; Holmdahl R; Jakobsson PJ; Skriner K; Klareskog L; Saevarsdottir S; Askling J
    Arthritis Rheumatol; 2020 Oct; 72(10):1658-1667. PubMed ID: 32475073
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Autoantibodies in rheumatoid arthritis: association with severity of disease in established RA.
    Agrawal S; Misra R; Aggarwal A
    Clin Rheumatol; 2007 Feb; 26(2):201-4. PubMed ID: 16572283
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.